Jay Andersen, Ph.D., Senior Research Fellow, Decision Sciences, Eli Lilly and Company
Balu Balasubramanian, Ph.D., Executive Director, Research and Development, Head of India Operations, Bristol-Myers Squibb Co. Co.
Christine Cioffe, V.M.D., Vice President, Enterprise-wide Planning and Portfolio Management, Merck & Co., Inc.
A. Maria Dahl, Ph.D., MBA, Vice President, Portfolio Management Oncology, IPSEN
Jennifer Daubenspeck, Associate Manager, R&D Operations, Resource Management, Capability Stewards, Bristol-Myers Squibb Co.
Melquiades de Jesus, Associate Director, R&D Operations, Resource Management, Capability Stewards, Bristol-Myers Squibb Co.
Shannon Diehl, MBA, PMP, Associate Director, Resource Planning, Johnson & Johnson
Robin G. Foldesy, Ph.D., Vice President, Portfolio Management, Wyeth Research
Bonnie Goldmann, Goldmann Consulting, LLC, former Senior Vice President at Merck and Johnson & Johnson
Richard Heaslip, Ph.D., Vice President, Project Management, Wyeth Research
Mellor Hennessy, Ph.D., Global Portfolio Strategist, Business Performance & Continuous Improvement, Global Development, AstraZeneca
Robert Kaupp, M.S., Director, Strategy and Portfolio Analysis, Johnson & Johnson
James Kirwin, MBA, Assistant Vice President, Clinical Resources and Process Development, Clinical Operations, Wyeth Research
Jack Kloeber, Ph.D., Senior Partner, Kromite
Jean-Claude Le Duc, Manager, Enrich Consulting, Inc.
Kevin Long, Manager, Research & Development Operations, Resource Management, Capability Stewards, Bristol-Myers Squibb Co.
Eric Morfin, PMP, Ph.D., Executive Director, Project Management, Amylin Pharmaceuticals, Inc.
Chad Nikel, Director of Strategy & Business Development, Integrated Project Management Company, Inc.
Carlos Nunes, Director, Portfolio Management & Analytics, Pfizer Inc.
Mohan Pandey, MBA, PMP, Head, Operations and Project Management, Biocon BMS R&D Center, Bristol-Myers Squibb India
Anders Persson, Ph.D., Director, Capacity Management, AstraZeneca
James F. Resch, Ph.D., Director, Strategic Intelligence, Discovery Strategy and Performance, AstraZeneca Pharmaceuticals, Inc.
Michael Soenen, Managing Partner, ClearTrial, LLC
Richard Sonnenblick, President, Enrich Consulting